{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:08:24Z","timestamp":1777583304904,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.euroneuro.2005.01.005","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T13:30:03Z","timestamp":1111671003000},"page":"497-503","source":"Crossref","is-referenced-by-count":15,"title":["Hydrosoluble fiber (Plantago ovata husk) and levodopa I: Experimental study of the pharmacokinetic interaction"],"prefix":"10.1016","volume":"15","author":[{"given":"Juan J.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelida","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrio","family":"Carriedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jose","family":"Diez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Sahagun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aranzazu","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Calle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2005.01.005_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.0954-6820.1975.tb19565.x","article-title":"Intestinal decarboxylation of orally administered l-dopa: influence of pharmacological preparations, dose magnitude, dose sequence and food intake","volume":"198","author":"Andersson","year":"1975","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00002826-199210000-00004","article-title":"Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease","volume":"15","author":"Astarloa","year":"1992","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib3","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S1590-8658(02)80180-3","article-title":"Effects of guar gum, ispaghula and microcrystalline cellulose on abdominal symptoms, gastric emptying, orocaecal transit time and gas production in healthy volunteers","volume":"34","author":"Bianchi","year":"2002","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00315415","article-title":"Pharmacokinetics and effects of levodopa in advanced Parkinson's disease","volume":"39","author":"Bredberg","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004836-199407000-00004","article-title":"Gastrointestinal dysfunction in Parkinson's disease: a report of clinical experience at a single center","volume":"19","author":"Byrne","year":"1994","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib6","first-page":"S15","article-title":"Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's disease","volume":"44","author":"Chase","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/thy.1998.8.667","article-title":"Effects of pharmacological fiber supplements on levothyroxine absorption","volume":"8","author":"Chiu","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.43.2.367","article-title":"Pharmacodynamic modelling of oral levodopa: clinical application in Parkinson's disease","volume":"43","author":"Contin","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003088-199630060-00004","article-title":"Pharmacokinetic optimisation in the treatment of Parkinson's disease","volume":"30","author":"Contin","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/BF00170645","article-title":"In vivo pharmacokinetics of levodopa and 3-O-methyldopa in muscle: a microdialysis study","volume":"344","author":"Deleu","year":"1991","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1212\/WNL.42.4.726","article-title":"Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology","volume":"42","author":"Edwards","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib12","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3109\/03639049509070866","article-title":"Effect of a bulk forming laxative on the bioavailability of carbamazepine in man","volume":"21","author":"Etman","year":"1995","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0896-6974(05)80140-9","article-title":"Carbamazepine-induced constipation","volume":"5","author":"Ettinger","year":"1992","journal-title":"J. Epilepsy"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib14","first-page":"870","article-title":"Influence of two commercial fibers in the pharmacokinetics of ethinilestradiol in rabbits","volume":"286","author":"Fern\u00e1ndez","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.ejcn.1601520","article-title":"The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal","volume":"57","author":"Frost","year":"2003","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/WNL.37.6.940","article-title":"Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating Parkinsonian patients","volume":"37","author":"Gancher","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0010-7824(00)00175-X","article-title":"Influence of two dietary fibers in the oral bioavailability and other pharmacokinetic parameters of ethinyloestradiol","volume":"62","author":"Garc\u00eda","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib18","first-page":"10","article-title":"Gastrointestinal dysmotility and central nervous system disorders: use of cisapride in patients with Parkinson's disease","volume":"11","author":"Garnett","year":"1996","journal-title":"Consult. Pharm."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib19","doi-asserted-by":"crossref","DOI":"10.1201\/b14095-3","article-title":"Multicompartment Models","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib20","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1023\/A:1010935228654","article-title":"A pharmacokinetic model to predict the PK interaction of l-dopa and benserazide in rats","volume":"18","author":"Grange","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.410270507","article-title":"l-dopa pharmacokinetics in plasma and cisternal and lumbar cerebrospinal fluid of monkeys","volume":"27","author":"Hammerstad","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02801866","article-title":"Effect of dietary fiber on proteolytic pancreatic enzymes in vitro","volume":"1","author":"Hansen","year":"1986","journal-title":"Int. J. Pancreatol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib23","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(82)80256-4","article-title":"Effect of dietary fiber on pancreatic enzyme activity in vitro","volume":"82","author":"Isaksson","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000199912","article-title":"Interference of dietary fibres with gastrointestinal enzymes in vitro","volume":"44","author":"Leng-Peschlow","year":"1989","journal-title":"Digestion"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1079\/BJN19910035","article-title":"Plantago ovata seeds as dietary fibre supplement, physiological and metabolic effects in rats","volume":"66","author":"Leng-Peschlow","year":"1991","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2125.1993.tb05691.x","article-title":"The effect of l-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man","volume":"35","author":"Lennern\u00e4s","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/jc.81.2.857","article-title":"Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients","volume":"81","author":"Liel","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410270105","article-title":"Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease","volume":"27","author":"Mouradian","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000113483","article-title":"Effects of chronic levodopa therapy on dopa pharmacokinetics","volume":"38","author":"Murata","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib30","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1023\/A:1018941200575","article-title":"The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum","volume":"11","author":"Nilsson","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.410220415","article-title":"On\u2013off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics","volume":"22","author":"Nutt","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002826-198403000-00002","article-title":"Pharmacokinetics of levodopa","volume":"7","author":"Nutt","year":"1984","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib33","first-page":"335","article-title":"Interaction between lithium salts and ispaghula husk","volume":"17","author":"Perlman","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2005.01.005_bib34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00002826-199112000-00004","article-title":"The influence of bromocriptine on the pharmacokinetics of levodopa in Parkinson's disease","volume":"14","author":"Rabey","year":"1991","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.ejcn.1600518","article-title":"Effect of psyllium on gastric emptying, hunger feeling and food intake in normal volunteers: a double blind study","volume":"52","author":"Rigaud","year":"1998","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/bmj.4.5727.93","article-title":"l-dopa treatment failure: explanation and correction","volume":"10","author":"Rivera-Calimlim","year":"1970","journal-title":"Br. Med. J."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.2042-7158.1991.tb06698.x","article-title":"Peripheral pharmacokinetic handling and metabolism of l-dopa in the rat: the effect of route of administration and carbidopa pretreatment","volume":"43","author":"Rose","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib38","first-page":"G662","article-title":"Canine gastric emptying of fiber meals: influence of meal viscosity and antroduodenal motility","volume":"249","author":"Russell","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.euroneuro.2005.01.005_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jps.2600690304","article-title":"Dosage form design for improvement of bioavailability of levodopa II: bioavailability of marketed levodopa preparations in dogs and Parkinsonian patients","volume":"69","author":"Sasahara","year":"1980","journal-title":"J. Pharm. Sci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T06:45:03Z","timestamp":1706078703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X05000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0924977X05000362"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2005.01.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}